Tyler E. Papp

1.3k total citations · 3 hit papers
17 papers, 593 citations indexed

About

Tyler E. Papp is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Tyler E. Papp has authored 17 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Immunology. Recurrent topics in Tyler E. Papp's work include RNA Interference and Gene Delivery (8 papers), Virus-based gene therapy research (5 papers) and Retinal Development and Disorders (4 papers). Tyler E. Papp is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Virus-based gene therapy research (5 papers) and Retinal Development and Disorders (4 papers). Tyler E. Papp collaborates with scholars based in United States, Sweden and Italy. Tyler E. Papp's co-authors include Hamideh Parhiz, Drew Weissman, Barbara L. Mui, Amir Yadegari, Ying K. Tam, Mohamad‐Gabriel Alameh, Vladimir V. Shuvaev, Hamna Shahnawaz, Vladimir R. Muzykantov and Dorottya Laczkó and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Tyler E. Papp

14 papers receiving 582 citations

Hit Papers

Highly efficient CD4+ T cell targeting and genetic recomb... 2021 2026 2022 2024 2021 2023 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tyler E. Papp United States 9 442 162 157 101 77 17 593
Laura Riolobos Spain 8 503 1.1× 227 1.4× 305 1.9× 158 1.6× 68 0.9× 9 862
Nigel Parker Finland 8 451 1.0× 284 1.8× 120 0.8× 35 0.3× 49 0.6× 20 597
Germán G. Gornalusse United States 7 451 1.0× 136 0.8× 278 1.8× 171 1.7× 67 0.9× 15 749
Anais K. Amaya Australia 6 597 1.4× 449 2.8× 107 0.7× 52 0.5× 55 0.7× 8 772
Cinnamon L Hardee United States 7 275 0.6× 168 1.0× 137 0.9× 109 1.1× 53 0.7× 10 438
Ulrike Mock Germany 11 526 1.2× 271 1.7× 463 2.9× 216 2.1× 134 1.7× 20 852
Petra Minder United States 8 271 0.6× 54 0.3× 90 0.6× 157 1.6× 37 0.5× 10 510
Juliane W. Schott Germany 11 310 0.7× 150 0.9× 94 0.6× 101 1.0× 41 0.5× 20 464
Alireza Shahryari Iran 10 497 1.1× 138 0.9× 106 0.7× 35 0.3× 57 0.7× 21 674

Countries citing papers authored by Tyler E. Papp

Since Specialization
Citations

This map shows the geographic impact of Tyler E. Papp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler E. Papp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler E. Papp more than expected).

Fields of papers citing papers by Tyler E. Papp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyler E. Papp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler E. Papp. The network helps show where Tyler E. Papp may publish in the future.

Co-authorship network of co-authors of Tyler E. Papp

This figure shows the co-authorship network connecting the top 25 collaborators of Tyler E. Papp. A scholar is included among the top collaborators of Tyler E. Papp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyler E. Papp. Tyler E. Papp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Yashaswini, Chittampalli N., Bruno Cogliati, Tyler E. Papp, et al.. (2026). Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction–associated steatohepatitis. Science Translational Medicine. 18(833). eadx0368–eadx0368.
3.
Kimura, Kenji, Caitlin M. Tilsed, Karen P. Fong, et al.. (2025). In Situ Tumor Vaccination Using Lipid Nanoparticles to Deliver Interferon-β mRNA Cargo. Vaccines. 13(2). 178–178. 1 indexed citations
4.
Reyes‐Esteves, Sahily, Marco E. Zamora, Yufei Wang, et al.. (2025). Targeted lipid nanoparticles containing IL-10 mRNA improve outcomes in experimental intracerebral hemorrhage. Journal of Neuroinflammation. 22(1). 234–234. 1 indexed citations
5.
Papp, Tyler E., Hamna Shahnawaz, Laura Breda, et al.. (2025). CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery. Molecular Therapy. 33(7). 3195–3208. 7 indexed citations
6.
Breda, Laura, Tyler E. Papp, Enrico Radaelli, et al.. (2024). An erythroid-specific lentiviral vector improves anemia and iron metabolism in a new model of XLSA. Blood. 145(1). 98–113.
7.
Tilsed, Caitlin M., Tyler E. Papp, Kenji Kimura, et al.. (2024). IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation. Proceedings of the National Academy of Sciences. 121(13). e2319856121–e2319856121. 24 indexed citations
8.
Parhiz, Hamideh, Vladimir V. Shuvaev, Qin Li, et al.. (2024). Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system. Molecular Therapy — Nucleic Acids. 35(2). 102175–102175. 11 indexed citations
9.
Mukalel, Alvin J., Alex G. Hamilton, Margaret M. Billingsley, et al.. (2024). Oxidized mRNA Lipid Nanoparticles for In Situ Chimeric Antigen Receptor Monocyte Engineering. Advanced Functional Materials. 34(27). 26 indexed citations
10.
Billingsley, Margaret M., Ningqiang Gong, Alvin J. Mukalel, et al.. (2023). In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism. Small. 20(11). e2304378–e2304378. 108 indexed citations breakdown →
11.
Breda, Laura, Tyler E. Papp, Michael Triebwasser, et al.. (2023). In vivo hematopoietic stem cell modification by mRNA delivery. Science. 381(6656). 436–443. 176 indexed citations breakdown →
12.
Breda, Laura, Tyler E. Papp, Michael Triebwasser, et al.. (2022). In Vivo Modification of Hematopoietic Stem Cells By Targeted Lipid Nanoparticles Encapsulating mRNA. Blood. 140(Supplement 1). 305–306. 1 indexed citations
13.
Tombácz, István, Dorottya Laczkó, Hamna Shahnawaz, et al.. (2021). Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs. Molecular Therapy. 29(11). 3293–3304. 183 indexed citations breakdown →
14.
McDougald, Devin S., et al.. (2019). AKT3 Gene Transfer Promotes Anabolic Reprogramming and Photoreceptor Neuroprotection in a Pre-clinical Model of Retinitis Pigmentosa. Molecular Therapy. 27(7). 1313–1326. 9 indexed citations
15.
McDougald, Devin S., Katherine C. Palozola, Tyler E. Papp, et al.. (2019). CRISPR Activation Enhances In Vitro Potency of AAV Vectors Driven by Tissue-Specific Promoters. Molecular Therapy — Methods & Clinical Development. 13. 380–389. 13 indexed citations
16.
Lim, James, Vidyullatha Vasireddy, Tyler E. Papp, et al.. (2019). Comparative AAV-eGFP Transgene Expression Using Vector Serotypes 1–9, 7m8, and 8b in Human Pluripotent Stem Cells, RPEs, and Human and Rat Cortical Neurons. Stem Cells International. 2019. 1–11. 26 indexed citations
17.
Bryant, Laura, Olga Lozynska, Tyler E. Papp, et al.. (2018). Identification of a novel pathogenic missense mutation inPRPF31using whole exome sequencing: a case report. British Journal of Ophthalmology. 103(6). 761–767. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026